Cognivia and Mayo Clinic Collaborate to Advance Behavioral Intelligence in Clinical Research and Patient Care
核心洞察
Cognivia (搜索) and Mayo Clinic announced a collaboration to advance behavioral intelligence across clinical research and clinical care, focusing on non-adherence, missed appointments, and clinical trial retention.
The partnership aims to make patient behavior measurable and actionable, helping healthcare organizations identify behavioral risks earlier and respond more effectively.
Cognivia (搜索)'s behavioral intelligence capabilities are designed to address behavioral factors that contribute to increased costs, operational inefficiencies, and variability in outcomes.
Cognivia (搜索) announced a collaboration with Mayo Clinic aimed at advancing behavioral intelligence across clinical research and clinical care, the company reported on June 23, 2026. Building on Cognivia's behavioral intelligence capabilities and Mayo Clinic's expertise in patient care and shared decision-making, the collaboration will initially focus on three critical drivers of outcomes across research and care settings: non-adherence, missed appointments, and clinical trial retention.
Across clinical trials, clinical research, and patient care, outcomes depend not only on having effective treatments or care plans, but also on whether patients can realistically follow them in daily life. Appointments, protocols, medications, and follow-up all shape both the real-world impact of care and the success of clinical trials.
Addressing Behavioral Drivers of Outcomes
Cognivia (搜索)'s behavioral intelligence capabilities are designed to make patient behavior measurable and actionable, with the goal of helping healthcare organizations identify risks earlier and respond more effectively. The collaboration will target non-adherence, missed appointments, and clinical trial dropout — behavioral factors that contribute to increased costs, operational inefficiencies, and variability in outcomes across both clinical research and clinical care.
Earlier visibility into behavioral risk can support stronger trial retention, more predictable study execution, and reduced uncertainty associated with behavioral variability. In clinical care, earlier visibility into behavioral risk can help care teams identify patients who may benefit from timely, targeted interventions to support adherence and prevent missed visits or treatment gaps from compounding.
Leadership Perspective
"Patient behavior is an important driver of outcomes across both clinical research and clinical care," said Dominique Demolle, Ph.D., Chief Executive Officer of Cognivia (搜索). "For decades, healthcare has focused on biological and clinical factors while having limited ability to systematically measure, let alone act on, behavioral drivers of outcomes. We are developing solutions designed to make these factors measurable and actionable in a way that can be consistently integrated into how research and care are conducted."
Financial Disclosure
Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.
About Cognivia (搜索)
Cognivia (搜索) develops behavioral intelligence solutions for healthcare, helping organizations measure, understand, and act on behavioral factors that influence adherence, engagement, and outcomes. By making patient behavior measurable and actionable, Cognivia helps healthcare organizations better understand sources of variability that are not captured by biological or operational data alone. Cognivia's capabilities support clinical research and clinical care, helping organizations improve patient engagement, optimize interventions, and deliver more predictable outcomes.